Future management of posterior uveal melanoma

Ophthalmic Practice

Volumn 19, Issue 1, 2001, Pages 4-

  Shields, J A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; RECOMBINANT ALPHA2B INTERFERON;

CANCER SURVIVAL; EDITORIAL; ENUCLEATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MELANOMA; METASTASIS INHIBITION; OPHTHALMOSCOPY; PROGNOSIS; RISK FACTOR; UVEA MELANOMA;

EID: 0035115737     PISSN: 08329869     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (6)

1. Management of posterior uveal melanoma
2. The incidence of malignant melanoma in the United States: Issues as we approach the 21st century
3. Risk factors for metastasis of small choroidal melanocytic lesions
4. Tumor doubling times in metastatic malignant melanoma of the uvea
5. Treatment of uveal melanoma metastatic to the liver: A review of the M.D. Anderson Cancer Center experience and prognostic factors
6. Neoadjuvant interferon alfa-2b treatment in a murine model for metastatic ocular melanoma